Suppr超能文献

Wistar大鼠致癌中期多器官生物测定中的淋巴细胞增殖反应和T淋巴细胞亚群

Lymphoproliferative response and T lymphocyte subsets in a medium-term multi-organ bioassay for carcinogenesis in Wistar rats.

作者信息

Spinardi-Barbisan A L, Kaneno R, Marchesan Rodrigues M A, Fávero Salvadori D M, Trindade Moreira E L, Barbisan L F, Viana de Camargo J L

机构信息

Department of Pathology, Faculty of Medicine, UNESP, Botucatu, 18618-000, SP, Brazil.

出版信息

Cancer Lett. 2000 Jun 30;154(2):121-9. doi: 10.1016/s0304-3835(00)00344-x.

Abstract

The lymphoproliferative response and T lymphocyte subsets were evaluated at different stages of carcinogenesis in male Wistar rats sequentially initiated with N-diethylnitrosamine (DEN), N-butyl-N-4(hydroxybutyl)nitrosamine (BBN), N-methyl-N-nitrosourea (MNU), dihydroxy-di-N-propylnitrosamine (DHPN) and N, N'-dimethylhydrazine (DMH) (DMBDD initiation). One group was evaluated at the 4th week and other initiated group at the 30th week. Two initiated groups were also exposed through diet to 2-acetylaminofluorene (2-AAF) or phenobarbital (PB), from the 6th until the 30th week. Two groups received only 2-AAF or PB until the 30th week. Five groups were studied to evaluate the effects of each initiator. The lymphoproliferative response was induced in vitro by concanavalin A and the percentage of T lymphocyte subsets was determined by flow cytometry. All groups submitted to initiation only, initiation plus promotion, or promotion only, developed significantly more preneoplastic lesions than the untreated control group. The main target organs for tumor development were the liver, colon, urinary bladder, kidneys and Zymbal glands, mainly in the group treated with DMBDD+2-AAF. There were no alterations of the lymphoproliferative response and of the T lymphocyte subsets percentage in the DMBDD-treated group at the 4th and 30th weeks. At the 30th week, the T lymphocyte subsets percentage was also not affected in the initiated groups after treatments with 2-AAF or PB. The lymphoproliferative response, however, was decreased in the DMBDD+2-AAF group and in the groups treated only with 2-AAF or PB. The present results indicate that the initiating chemicals used in the DMBDD initiation protocol do not exert any influence on the immune system. The alteration of lymphoproliferative response induced at the advanced stage of carcinogenesis without alteration of T lymphocyte subsets may indicate that the influence of 2-AAF and PB on the immune system is functional and not toxic.

摘要

在雄性Wistar大鼠中,依次用N-二乙基亚硝胺(DEN)、N-丁基-N-4(羟丁基)亚硝胺(BBN)、N-甲基-N-亚硝基脲(MNU)、二羟基二-N-丙基亚硝胺(DHPN)和N,N'-二甲基肼(DMH)(DMBDD启动)诱导致癌作用的不同阶段,评估淋巴细胞增殖反应和T淋巴细胞亚群。一组在第4周进行评估,另一启动组在第30周进行评估。从第6周直到第30周,两个启动组还通过饮食接触2-乙酰氨基芴(2-AAF)或苯巴比妥(PB)。两个组仅接受2-AAF或PB直到第30周。研究了五组以评估每种启动剂的作用。通过伴刀豆球蛋白A体外诱导淋巴细胞增殖反应,并通过流式细胞术测定T淋巴细胞亚群的百分比。所有仅接受启动、启动加促进或仅促进的组,与未处理的对照组相比,发生的癌前病变明显更多。肿瘤发生的主要靶器官是肝脏、结肠、膀胱、肾脏和耳下腺,主要在接受DMBDD + 2-AAF治疗的组中。在第4周和第30周,DMBDD治疗组的淋巴细胞增殖反应和T淋巴细胞亚群百分比没有改变。在第30周,用2-AAF或PB治疗后的启动组中,T淋巴细胞亚群百分比也未受影响。然而,DMBDD + 2-AAF组以及仅用2-AAF或PB治疗的组中,淋巴细胞增殖反应降低。目前的结果表明,DMBDD启动方案中使用的启动化学物质对免疫系统没有任何影响。在致癌作用晚期诱导的淋巴细胞增殖反应改变而T淋巴细胞亚群未改变,可能表明2-AAF和PB对免疫系统的影响是功能性的而非毒性的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验